Abstract
Interferon has been shown to be an effective treatment for some patients with chronic hepatitis C. In this study, the value of retreatment of nonresponders to interferon was investigated. Thirty-eight patients with hepatitis C virus (HCV)-RNA-positive chronic hepatitis C virus (HCV)-RNA-positive chronic hepatitis C who had been treated with betainterferon but still showed an alanine aminotransferase (ALT) level>50 KU upon completion of therapy were retreated with alpha-interferon. Eight patients (21.1%) had normalization of ALT levels after interferon retreatment were studied. Of 16 patients with transient HCV-RNA negativity 1 month after the initial interferon therapy, 7 (43.8%) had a complete response, with normalization of ALT levels and undetectable HCV-RNA, more than 6 months after interferon retreatment. On the other hand, of the 22 patients with HCV-RNA activity 1 month after the initial interferon therapy, only 1 (4.5%) had a complete response. Multivariate analysis, using a multiple logistic model, indicated that a complete response to readministration of interferon was most strongly correlated to transient negative conversion for HCV-RNA after the initial course of treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A non-B hepatitis with recombinant human alpha interferon J Engl J Med 1986;315:1575–1578.
Thompson BJ, Doran M, Lever AML, et al. Alpha interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1987;I:539–541.
Di Bisceglie AM, Martin P, Kassiandics C, et al. Recombinant interferon alpha therapy for chronic hepatitis C N Engl J Med 1989;321:1506–1510.
Kiyosawa K, Sodeyama S, Oike Y, et al. Treatment of chronic non-A non-B hepatitis with human interferon beta. In: Zuckerman A (ed) Viral hepatitis and liver disease New York: Alan R. Liss, 1988;898–901.
Fujioka S, Hino K, Fukuhara A, et al. Voluminal comparative tests with human interferon-beta for non-A non-B chronic hepatitis (in Japanese). Acta Hepatol Jpn 1989;30:516–521.
Kakumu S, Arao M, Yoshioka E, et al. Recombinant human interferon therapy for chronic non-A, non-B hepatitis: Second report. Am J Gastroenterol 1989;85:655–659.
Omata M, Ito Y, Yokosuka O, et al. Histological changes of liver by the treatment of chronic non-A, non-B hepatitis with recombinant leucocyte interferon alpha: Comparison with histolotical changes in chronic hepatitis B. Dig Dis Sci 1989; 34:330–337.
Kumada H, Arase Y, Chayama K, et al. Usefulness of HCV antibody titer in interferon therapy (in Japanese). Acta Hepatol Jpn 1990;31:902–906.
Chayama K, Saito S, Arase Y, et al. Sensitive and specific detection of hepatitis C virus RNA with nested polymerase chain reaction and digoxigenin-labelled cDNA probe (in Japanese). Acta Hepatol Jpn 1991;32:135–140.
Arase Y, Kumada H, Chayama K, et al. Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA-positive chronic hepatitis. Gastroenterol Jpn 1992;33:805–806.
Arase Y, Chayama K, Tsubota A, et al. Interferon therapy for HCV-RNA-positive chronic hepatitis. Acta Hepatol Jpn 1993;34:1–7.
Kubo Y, Takeuchi K, Boonmar S, et al. A cDNA fragment of hepatitis C virus isolated from an implicated donor or posttransfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res 1989;17:367.
Chayama K, Tsubota A, Arase Y, et al. Genotypical classification of hepatitis C virus genome with polymerase chain reaction using a mixed primer set. Acta Hepatol Jpn 1993;33:805–806.
Okamoto H, Sagiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical survey and tracing infectious sources. J Gen Virol 1990;60:167–177.
Dixon WJ, Brown MB, Engleman L, et al. BMDP Statistical software. Berkeley: University of California Press, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arasf, Y., Kumada, H., Chayama, K. et al. Interferon retreatment of nonresponders with HCV-RNA-Positive chronic hepatitis C. J Gastroenterol 29, 299–304 (1994). https://doi.org/10.1007/BF02358369
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02358369